# WeFlow-EndoSeal™ Aorta Vascular Plug System for the Treatment of Stanford Type B Aortic Dissection

> **NCT07658651** · NA · RECRUITING · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 256 (estimated)

## Conditions studied

- Aortic Dissection Type B

## Interventions

- **DEVICE:** WeFlow-EndoSeal™ Aorta Vascular Plug System
- **PROCEDURE:** Thoracic Endovascular Aortic Repair（TEVAR）

## Key facts

- **NCT ID:** NCT07658651
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2032-03-01
- **Final completion:** 2032-03-01
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658651, "WeFlow-EndoSeal™ Aorta Vascular Plug System for the Treatment of Stanford Type B Aortic Dissection". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*